Abstract
Risk factors that predispose to the pathogenesis of coronary artery disease (CAD) in young and middle-aged persons include cigarette smoking,1–13hypercholesterolemia,4,14–23 systolic and diastolic hypertension,24–32 diabetes mellitus,17,33–40 obesity,41,–42 and physical inactivity.9,43–46 Cigarette smoking, systolic and diastolic hypertension, and hypercholesterolemia are the three major risk factors contributing to the development of CAD in young and middle-aged persons. Systolic and diastolic hypertension and diabetes mellitus are the major risk factors predisposing to the pathogenesis of atherothrombotic brain infarction(ABI).31,47–51 The relationship of cigarette smoking,47–50,52 serum total cholesterol,47–49,53,54 and obesity47–51 to ABI is unclear. This chapter will discuss risk factors predisposing to the pathogenesis of CAD and of ABI in the elderly person.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hammond, E. C., 1964, Smoking in relation to mortality and morbidity. Findings in first thirty-four months of follow-up in prospective study started in 1959, J. Natl Cancer Inst. 32:1161–1188.
Doyle, J. T., Dawber, T. R., Kannel, W. B., et al, 1964, The relationship of cigarette smoking to coronary heart disease: the second report of the combined experience of Albany, NY, and Framingham, Mass. studies, JAMA 190:886–890.
Doll, R. and Peto, R., 1976, Mortality in relation to smoking: 20 years’ observations on male British doctors, Br. Med. J. 2:1525—1536.
Pooling Project Research Group, 1978, Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and EGG abnormalities to incidence of major coronary events: fmal report of the Pooling Project, J. Chronic Dis. 31:201–306.
Friedman, G. D., Dales, L. G., and Ury, H. K., 1979, Mortality in middle- aged smokers and nonsmokers, N. Engl. J. Med. 300:213—217.
Doll, R., Gray, R., Hafner, B., and Peto, R., 1980, Mortality in relation to smoking: 22 years’ observations on female British doctors, Br. Med. J. 1:967–971.
Jenkins, G. D., Rosenman, R. H., and Zyzanski, S. J., 1968, Gigarette smoking: its relationship to coronary heart disease and related risk factors in the Western collaborative group study. Circulation 38:1140–1155.
Stamler, J., Berkson, D. M., Levinson, M., et al., 1966, Goronary heart disease. Status of preventive efforts. Arch. Environ. Health 13:322—335.
Shapiro, S., Weinblatt, E., Frank, G. W., and Sager, R. V., 1969, Incidence of coronary heart disease in a population insured for medical care (HIP): myocardial infarction, angina pectoris, and possible myocardial infarction. Am. J. Puhl. Health 59(Suppl): 1–101.
Stone, D., Shapiro, S., Rosenberg, L., et al, 1978, Relation of cigarette smoking to myocardial infarction in young women, N. Engl. J. Med. 298:1273–1276.
Spain, D. M. and Bradess, V. A., 1970, Sudden death from coronary heart disease. Survival time, frequency of thrombi, and cigarette smoking. Chest 58:107–110.
Spain, D. M., Siegel, H., and Bradess, V. A., 1973, Women smokers and sudden death. The relationship of cigarette smoking to coronary disease, JAMA 224:1005–1007.
Doyle, J. T., Kannel, W. B., McNamara, P. M., et. al., 1976, Factors related to suddenness of death from coronary disease: Gombined Albany—Framingham studies. Am. J. Cardiol. 37:1073–1078.
Robertson, T. L., Kato, H., Gordon, T., et al., 1977, Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and Galifornia: coronary heart disease risk factors in Japan and Hawaii, Am. J. Cardiol 39:244–249.
Keys, A. (ed. ), 1970, Goronary heart disease in seven countries. Circulation 41(Suppl 1):1–211.
Waiden, R. T., Schaefer, L. A., Lemon, F. R., et al, 1964, Effect of environment on the serum cholesterol-triglyceride distribution among Seventh- day Adventists, Am. J. Med. 36:269–276.
Aronow, W. S., Uyeyama, R. R., and Cassidy, J., 1973, Serum lipids, serum uric acid and glucose tolerance in coronary heart disease, J. Am. Geriatr. Soc. 21:58–62.
Gotto, A. M., Gorry, G. A., Thompson, J. R., et. al., 1977, Relationship between plasma lipid concentrations and coronary artery disease in 496 patients. Circulation 56:875—883.
Kannel, W. B., Castelli, W. P., and Gordon, T., 1979, Cholesterol in the prediction of atherosclerotic disease: New perspectives based on the Fra- mingham Study, Ann. Intern. Med. 90:85–91.
Vlietstra, R. E., Frye, R. L., Kronmal, R. A., et al, 1980, Risk factors and angiographic coronary artery disease: A report from the Coronary Artery Surgery Study (CASS), Circulation 62:254–261.
Hjermann, I., Velve-Byre, K., Holme, I., and Leren, P., 1981, Effect of diet and smoking intervention on the incidence of coronary heart disease: report from the Oslo Study Group of a randomized trial in healthy men. Lancet 2:1303–1310.
22. The Lipid Research Clinics Coronary Primary Prevention Trial Results, 1984, I. Reduction in incidence of coronary heart disease: Lipid Research Clinics Program, JAMA 251:351–364.
23. The Lipid Research Clinics Coronary Primary Prevention Trial Results, 1984, II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering, JAMA 251:365–374.
Kannel, W. B., Dawber, T. R., and McGee, D. L., 1980, Perspectives on systolic hypertension. The Framingham Study, Circulation 61:1179—1182.
Kannel, W. B., Sorlie, P., and Gordon, T., 1980, Labile hypertension: A faulty concept? The Framingham Study, Circulation 61:1183–1187.
Morton, P. A., 1959, Ordinary insurance: the build and blood pressure study. Trans. Soc. Actuar. 11:987–997.
Rabkin, W. S., Mathewson, F. A. L., and Tate, R. B., 1978, Predicting risk of ischemic heart disease and cerebrovascular disease from systolic and diastolic blood pressures, Ann. Intern. Med. 88:342—345.
Shea, S., Cook, E. F., Kannel, W. B., and Goldman, L., 1985, Treatment of hypertension and its effect on cardiovascular risk factors: Data from the Framingham Heart Study, Circulation 71:22–30.
Veterans Administration Cooperative Study Group on Antihypertensive Agents, 1967, Effects of treatment on morbidity in hypertension. 1. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg, JAMA 202:1028–1034.
Veterans Administration Cooperative Study Group on Antihypertensive Agents, 1970, Effects of treatment on morbidity in hypertension. IL Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg, JAMA 213:1143–1152.
Hypertension Detection and Follow-up Program Cooperative Group, 1979, Five-year findings of the Hypertension Detection and Follow-up Program. 1. Reduction in mortality of persons with high blood pressure, including mild hypertension, JAMA 242:2562–2571.
Report by the Management Committee, 1980, The Australian therapeutic trial in mild hypertension, Lancet 1:1261–1267.
Aronow, W. S., Suryanarayana, B. V., and Kent, J. R., 1971, Myocardial infarction and carbohydrate metabolism relating to diabetes mellitus, California Med, 115:16–20.
Heinle, R. A., Levy, R. I., Fredrickson, D. S., and Gorlin, R., 1969, Lipid carbohydrate abnormalities in patients with angiographically documented coronary artery disease. Am. J. Cardiol. 24:178—186.
Falsetti, H. L., Schnatz, J. D., Greene, D. G., and Bunnell, I. L., 1970, Serum lipids and glucose tolerance in angiographically proved coronary artery disease. Chest 58:111–115.
Bryfogle, J. W., and Bradley, R. F., 1957, The vascular complications of diabetes mellitus: A clinical study. Diabetes 6:159—167.
Ostrander, L. D., Jr., Frances, T., Jr., Hayner, N. S., et al, 1965, The relationship of cardiovascular disease to hyperglycemia, Ann. Intern. Med. 62:1188–1198.
Garcia, M. J., McNamara, P. M., Gordon, T., and Kannel, W. B., 1976, Morbidity and mortality of diabetes in the Framingham population. 16 year follow-up. Diabetes 23:105–111.
Kannel, W. B. and McGee, D. L., 1979, Diabetes and cardiovascular disease: the Framingham study, JAMA 241:2035–2038.
Kannel, W. B., McNamara, P. M., Feinleib, M., and Dawber, T. R., 1970, The unrecognized myocardial infarction: 14 year follow-up experience in the Framingham study. Geriatrics 25:75—87.
Rabkin, S. W., Mathewson, F. A. L., and Hsu, P. H., 1977, Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26-year observation period: The Manitoba study. Am. J. Cardiol. 39:452–458.
Hubert, H. B., Feinleib, M., McNamara, P. M., and Gastelli, W. P., 1983, Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study, Circulation 67:968–977.
Paffenbarger, R. S., and Hale, W. E., 1975, Work activity and coronary heart mortality, N. Engl. J. Med. 292:545–550.
Kannel, W. B., and Sorlie, P., 1979, Some health benefits of physical activity: the Framingham study. Arch. Intern. Med. 139:857—861.
Paffenbarger, R. S., Hyde, R. T., Wing, A. L., and Hsieh, G-G, 1984, A natural history of athleticism and cardiovascular health, JAMA 252:491–495.
Garcia-Palmieri, M. R., Gostas, R., Jr., Gruz-Vidal, M., et al, 1982, Increased physical activity: a protective factor against heart attacks in Puerto Rico, Am. J. Cardiol. 50:749–755.
Wolf, P. A. and Kannel, W. B., 1981, Gontrollable risk factors for stroke: Preventive implications of trends in stroke mortality, in: Diagnosis and Management of Stroke and TIA’s (J. S. Meyer, and T. Shaw, eds. ), Addison- Wesley, Reading, MA, pp. 25–61.
Takeya, Y., Popper, J. S., Shimizu, Y., et al., 1984, Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Incidence of stroke in Japan and Hawaii, Stroke 15:15–23.
Dyken, M. L., Wolf, P. A., Barnett, H. J. M., et al, 1984, Risk factors in stroke. A statement for physicians by the Subcommittee on Risk Factors and Stroke of the Stroke Council, Stroke 15:1105—1111.
Paffenbarger, R. S., Jr. and Williams, J. L., 1967, Chronic disease in former college students. V. Early precursors of fatal stroke. Am. J. Public Health 57:1290–1299.
Chapman, J. M., Reeder, L. G., Borun, E. R., et al, 1966, Epidemiology of vascular lesions affecting the central nervous system: the occurrence of strokes in a sample population under observation for cardiovascular disease, Am. J. Public Health 56:191–201.
Hammond, E. C., 1964, Smoking in relation to death rates of one million men and women, Natl. Cancer Inst. Monogr. 19:127—204.
Dyer, A. R., Stamler, J., Paul, O., et al., 1981, Serum cholesterol and risk of death from cancer and other causes in three Chicago epidemiological studies, J. Chronic Dis. 34: 249–260.
Mathew, N. T., Davis, D., Meyer, J. S., and Chander, K., 1975, Hyperlipoproteinemia in occlusive cerebrovascular disease, JAMA 232:262—266.
Aberg, A., Bergstrand, R., Johansson, S., et al., 1983, Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. Br. Heart J. 44:416–422.
Hammond, E. C. and Garfmkel, L., 1969, Coronary heart disease, stroke, and aortic aneurysm. Factors in the etiology, Arch. Environ. Health 19:167—182.
Auerbach, O., Carter, H. W., Garfmkel, L., and Hammond, E. C., 1976, Cigarette smoking and coronary artery disease: a macroscopic and microscopic study, Chest 70:697–705.
Strong, J. P. and Richards, M. L., 1976, Cigarette smoking and atherosclerosis in autopsied men, Atherosclerosis 23:451–476.
McMillan, G. C. and Aronow, W. S., 1976, Recommendations: subsection B: relation of smoke components to cardiovascular disease, in: Smoking and Health. I. Modifying the Risk for the Smoker. Proceedings Third World Conference on Smoking and Health (E. L. Wynder, D. Hoffman, and G. B. Gori, eds. ). Government Printing Office, Washington, DC, pp. 548—549.
Kannel, W. B., 1981, Update on the role of cigarette smoking in coronary artery disease. Am. Heart J. 101:319–328.
Aronow, W. S., Kaplan, M. A., and Jacob, D., 1968, Tobacco: a precipitating factor in angina pectoris, Ann. Intern. Med. 69:529—536.
Aronow, W. S. and Swanson, A. J., 1969, The effect of low-nicotine cigarettes on angina pectoris, Ann. Intern. Med. 71:599–601.
Aronow, W. S. and Rokaw, S. N., 1971, Carboxyhemoglobin caused by smoking non-nicotine cigarettes: effects on angina pectoris. Circulation 44:782–788.
Aronow, W. S. and Cassidy, J., 1975, Effect of smoking marihuana versus a high-nicotine cigarette on angina pectoris, Clin. Pharmacol. Ther. 17:549—554.
Aronow, W. S., 1980, Effect of non-nicotine cigarettes and carbon monoxide on angina. Circulation 61:262—265.
Aronow, W. S., Dendinger, J., and Rokaw, S. N., 1971, Heart rate and carbon monoxide level after smoking high-, low-, and non-nicotine cigarettes: A study in male patients with angina pectoris, Ann. Intern. Med. 74:697–702.
Aronow, W. S., Goldsmith, J. R., Kern, J. C., et al, 1974, Effect of smoking cigarettes on cardiovascular hemodynamics, Arch. Environ. Health 28:330–332.
Aronow, W. S., Cassidy, J., Vangrow, J. S., et al, 1974, Effect of cigarette smoking and breathing carbon monoxide on cardiovascular hemodynamics in anginal patients. Circulation 50:340–347.
Aronow, W. S., Harris, C. N., Isbell, M. W., et al, 1972, Effect of freeway travel on angina pectoris, Ann. Intern. Med. 77:669—676.
Aronow, W. S. and Isbell, M. W., 1973, Carbon monoxide effect on exercise-induced angina pectoris, Ann. Intern. Med. 79:392–395.
Aronow, W. S., 1981, Aggravation of angina pectoris by two percent car- boxyhemoglobin. Am. Heart J. 101:154—157.
Levine, P. H., 1973, An acute effect of cigarette smoking on platelet function: A possible link between smoking and arterial thrombosis. Circulation 48:619–623.
Bellet, S., Deguzman, N. T., Kostis, J. B., et al, 1972, The effect of inhalation of cigarette smoke on ventricular fibrillation threshold in normal dogs and in dogs with acute myocardial infarction. Am. Heart J. 83:67–76.
DeBias, D. A., Banerjee, C. M., Birkhead, N. C., et al, 1973, Carbon monoxide inhalation effects following myocardial infarction in monkeys. Arch. Environ. Health 27:161–167.
Birnstingl, M. A., Brinson, K., and Chakrabarti, B. K., 1971, The effect of short-term exposure to carbon monoxide on platelet stickiness, Br. J. Surg. 58:837–839.
DeBias, D. A., Banerjee, C. M., Birkhead N. C., et al, 1976, Effects of carbon monoxide inhalation on ventricular fibrillation, Arch. Environ. Health 31:38–42.
Aronow, W. S., Stemmer, E. A., Wood, B., et al, 1978, Carbon monoxide and ventricular fibrillation threshold in dogs with acute myocardial injury. Am. Heart J. 95:754–756.
Castelli, W. P., Dawber, T. R., Feinleib, M., et al, 1981, The filter cigarette and coronary heart disease. The Framingham sudy. Lancet 2:109–113.
Kaufman, D. W., Helmrich, S. P., Rosenberg, L., et al, 1983, Nicotine and carbon monoxide content of cigarette smoke and the risk of myocardial infarction in young men, N. Engl J. Med. 308: 409–413.
Jajich, C. L., Ostfeld, A. M., and Freeman, D. H., Jr., 1984, Smoking and coronary heart disease mortality in the elderly, JAMA 252:2831–2834.
Kannel, W. B., and Brand, F. N., 1985, Cardiovascular risk factors in the elderly, in: Principles of Geriatric Medicine (R. Andres, E. L. Bierman, and W. R. Hazzard, eds. ), McGraw-Hill, New York, pp. 104–119.
Aronow, W. S., Starling, L., Etienne, F., et al, 1986, Risk factors for coronary artery disease in persons older than 62 years in a long-term health care facility. Am. J. Cardiol 57:518–520.
Aronow, W. S., Etienne, F., D’Alba, P., and Ronquillo, J., 1988, Risk factors correlated with new coronary events in elderly persons, Clin. Res, 36:2A.
Grundy, S. M., 1984, Hyperlipoproteinemia: metabolic basis and rationale for therapy, Am. J. Cardiol. 54:20C-26C.
Castelli, W. P., Doyle, J. T., Gordon, T., et al, 1977, HDL cholesterol and other lipids in coronary heart disease: The Cooperative Lipoprotein Phe- notyping Study, Circulation 55:767–772.
Miller, N. E., Thelle, D. S., F0rde, O. H., and Mj0s, O. D., 1977, The Troms0 heart-study. High density lipoprotein and coronary heart-disease: A prospective case-study, Lancet 1:965—967.
Kannel, W. B., 1983, High-density lipoproteins: epidemiologic profile and risks of coronary artery disease. Am. J. Cardiol. 52:9B-12B.
Goldstein, J. L., Hazzard, W. R., Schrott, H. G., et al, 1973, Hyper- lipidemia in coronary heart disease: I. Lipid levels in 500 survivors of myocardial infarction, J. Clin. Invest. 52:1533—1543.
Carlson, L. A., Böttiger, L. E., and Ähfeldt, P. E., 1979, Risk factors for myocardial infarction in the Stockholm prospective study: A 14-year fol- low-up focusing on the role of plasma triglycerides and cholesterol, Acta Med. Scand. 206:351–360.
Hulley, S. B., Rosenman, R. H., Bawol, R. D., and Brand, R. J., 1980, Epidemiology as a guide to clinical decisions: the association between triglyceride and coronary heart disease, N. Engl. J. Med. 302:1383–1389.
Consensus Conference, 1984, Treatment of hypertriglyceridemia, JAMA 251:1196–1200.
Dayton, S., Pearce, M. L., Hashimoto, S., et al., 1969, A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis, Circulation 40(Suppl II): 1–63.
Turpeinen, O., Karvonen, M. J., Pekkarinen, M., et al, 1979, Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study, Int. J. Epidemiol. 8:99–118.
Multiple Risk Factor Intervention Trial Research Group, 1983, Multiple risk factor intervention trial: Risk factor changes and mortality results, JAMA 248:1465–1477.
Kushi, L. H., Lew, R. A., Stare, F. J., et al, 1985, Diet and 20-year mortality from coronary heart disease: The Ireland-Boston Diet-Heart Study, N. Engl. J. Med. 312:811–818.
95. The Coronary Drug Project Research Group, 1975, Clofibrate and niacin in coronary heart disease, JAMA 231:360–381.
Canner, P. L., Berge, K. G., Wenger, N. K., et al., 1986, Fifteen year mortality in coronary drug project patients: long term benefit with niacin, J. Am. Coll. Cardiol. 8:1245–1255.
Brensike, J. F., Levy, R. L., Kelsey, S. F., et al., 1984, Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI type II Coronary Intervention Study, Circulation 69:313–324.
Levy, R. L, Brensike, J. F., Epstein, S. E., et al, 1984, The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of the NHLBI type II Coronary Intervention Study, Circulation 69:325–337.
Arntzenius, A. C., Kromhout, D., Barth, J. D., et al, 1985, Diet, lipoproteins, and the progression of coronary atherosclerosis: the Leiden Intervention Trial, N. Engl]. Med. 312:805–811.
Consensus Conference, 1985, Lowering blood cholesterol to prevent heart disease, JAMA 253:2080–2086.
Dyer, A. R., Stamler, J., Shekelle, R. B., et al, 1977, Hypertension in the elderly, Med. Clin. North Am. 61:513–529.
102. The Working Group on Hypertension in the Elderly, 1986, Statement on hypertension in the elderly, JAMA 256:70–74.
The 1984 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure, 1984, Arch. Intern. Med. 144:1045–1057.
National Heart Foundation of Australia Study, 1981, Treatment of mild hypertension in the elderly: Report by the Management Committee, Med. J. Aust. 2:398–402.
Amery, A., Birkenhäger, W., Brixko, V., et al, 1985, Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial, Lancet 1:1349–1354.
Aronow, W. S., July, 1985, Coronary risk factors, part 3: Hypertension, Fam. Pract. Recertification 7:53–74.
Drayer, J. I. M., Gardin, J. M., Weber, M. A., and Aronow, W. S., 1982, Changes in ventricular septal thickness during diuretic therapy, Clin. Pharmacol. Ther. 32:283–288.
Drayer, J. I. M., Gardin, J. M., Weber, M. A., and Aronow, W. S., 1982, Changes in cardiac anatomy and function during therapy with alpha-meth- yldopa: An echocardiographic study, Curr. Ther. Res. 32:856–865.
Drayer, J. I. M., Gardin, J. M., Weber, M. A., and Aronow, W. S., 1983, Cardiac muscle mass during vasodilation therapy of hypertension, Clin. Phar. Ther. 33:727–732.
Rowe, J. W., 1983, Systolic hypertension in the elderly, N. Engl. J. Med. 309:1246–1247.
Hulley, S. B., Furberg, C. D., Gurland, B., et al., 1985, Systolic Hypertension in the Elderly Program (SHEP): Antihypertensive efficacy of chlorthalidone, Am. J. Cardiol. 56:913–920.
Hamby, R. I., Zoneraich, S., and Sherman, L., 1974, Diabetic cardiomyopathy, JAMA 229:1749–1754.
Kannel, W. B., Hjortland, M., and Castelli, W. P., 1974, Role of diabetes in congestive heart ifailure: The Framingham study. Am. J. Cardiol. 34:29–34.
Atherosclerosis Study Group, 1984, Optimal resources for primary prevention of atherosclerotic diseases. Circulation 70:157A—205A.
Aronow, W. S., 1985, Coronary risk factors, part 4: Diabetes mellitus, hyperuricemia, obesity, and physical inactivity, Fam. Pract. Recertification 7:69–89.
Chiang, B. N., Perlman, L. V., and Epstein, F. H., 1969, Overweight and hypertension. A review. Circulation 39:403—421.
Ashley, F. W., and Kannel, W. B., 1974, Relation of weight change to changes in atherogenic traits. The Framingham study., J. Chronic Dis. 27:103–114.
Montoye, H. J., Epstein, F. H., and Kjelsberg, M. O., 1966, Relationship between serum cholesterol and body fatness. An epidemiologic study. Am. J. Clin. Nutr. 18:397–406.
Krotkiewski, M., Mandroukas, K., Sjostrom, L., et al., 1979, Effects of long- term physical training on body fat, metabolism, and blood pressure in obesity. Metabolism 28:650–658.
Caggiula, A. W., Christakis, G., Farrand, M., et al, 1981, The multiple risk factor intervention trial (MRFIT). IV. Intervention on blood lipids. Prev. Med. 10:443–475.
Huttunen, J. K., Länsimies, E., Voutilainen, E., et al., 1979, Effect of moderate physical exercise on serum lipoproteins. A controlled clinical trial with special references to serum high-density lipoproteins. Circulation 60:1220–1229.
Richter, E. A., Ruderman, M. B., and Schneider, S. H., 1981. Diabetes and exercise. Am. J. Med. 70:201–209.
Williams, M. A., Maresh, C. M., Aronow, W. S., et al, 1984, The value of early out-patient cardiac exercise programs for the elderly in comparison with other selected age groups, Eur. Heart J. 5(Suppl E):113—115.
Naughton, J., 1985, Role of physical activity as a secondary intervention for healed myocardial infarction. Am. J. Cardiol. 55:21D-26D.
Gordon, T. G., Kannel, W. B., Hjortland, M. C., and McNamara, P. M., 1978, Menopause and coronary heart disease: The Framingham study, Ann. Intern. Med. 89:157–161.
Rogers, R. L., Meyer, J. S., Judd, B. W., and Mortel, K. F., 1985, Abstention from cigarette smoking improves cerebral perfusion among elderly chronic smokers, JAMA 253:2970–2974.
Aronow, W. S., Starling, L., Etienne, F., et al, 1987, Risk factors for athe- rothrombotic brain infarction in persons over 62 years of age in a long- term health care facility, J. Am. Geriatr. Soc. 35:1—3.
Aronow, W. S., Gutstein, H., Lee, N. H., and Edwards, M., 1988, Risk factors correlated with new atherothrombotic brain infraction in elderly persons, Clin. Res. 36:9A.
Shekelle, R. B., Ostfeld, A. M., and Klawans, H. L., Jr., 1974, Hypertension and risk of stroke in an elderly population. Stroke 5:71–75.
Medical Research Council Working Party, 1985, MRG trial of treatment of mild hypertension: principal results, Br. Med. J. 291:97–104.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Publishing Corporation
About this chapter
Cite this chapter
Aronow, W.S. (1988). Risk Factors for Coronary Artery Disease and Atherothrombotic Brain Infarction in the Elderly. In: Gambert, S.R. (eds) Contemporary Geriatric Medicine. Contemporary Geriatric Medicine, vol 3. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5427-7_9
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5427-7_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5429-1
Online ISBN: 978-1-4684-5427-7
eBook Packages: Springer Book Archive